Evaluation Of Missed Osteoporosis Diagnoses, And Preference Between Once Monthly Ibandronate And Once Weekly Alendronate
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
This is a two part study (screening and treatment). The first part (screening) is designed to
evaluate the percentage of patients missed in diagnosing osteoporosis by general
practitioners (GP's). The second part (treatment) is designed to determine the preference by
patients for the once monthly ibandronate or the once weekly alendronate.